Variables |
No sampled |
SARS-CoV-2 |
RSV |
Influenza-A |
Influenza-B |
Gender |
|
|
|
|
|
Male |
510 (40.1%) |
59 (11.6%) |
4 (0.8%) |
38 (7.4%) |
10
(1.96%) |
Female |
761 (59.9%) |
118 (15.5%) |
8 (1.1%) |
34 (4.4%) |
15
(1.97%) |
Age |
|
|
|
|
|
Adults |
1154 (90.8%) |
159 (13.8%) |
10 (0.9%) |
65 (5.6%) |
21
(1.8%) |
Minors |
117 (9.2%) |
18 (15.2%) |
2 (1.6%) |
7 (5.9%) |
4
(3.3%) |
Sites |
|
|
|
|
|
Iten |
479 (37.7%) |
30 (6.2) |
1 (0.21%) |
5 (1%) |
1
(0.2%) |
Olenguruone |
430 (33.8%) |
69 (16.0%) |
4 (0.93%) |
27 (6.3%) |
16
(3.7%) |
Kapsabet |
203 (16%) |
21 (10.3%) |
7 (3.4%) |
22 (10.8%) |
4
(1.97%) |
Molo |
159 (12.5%) |
57 (35.85%) |
0 (0%) |
19 (11.95%) |
4
(2.5%) |
Total N (%) |
1271 |
177 (13.93%) |
12 (0.94%) |
73 (5.7%) |
25
(1.96%) |